Which of the following is an FDA label indication for Enalapril Maleate?

Which of the following is an FDA label indication for Enalapril Maleate?

• A. Hypertension
• B. Asthma
• C. Cholesterol management
• D. Diabetes management

Answer: (A)

Enalapril Maleate is primarily indicated for the treatment of hypertension, which is high blood pressure. As an ACE (Angiotensin-Converting Enzyme) inhibitor, Enalapril works by relaxing blood vessels, allowing blood to flow more easily, thus lowering blood pressure. This indication is important because managing hypertension is crucial to prevent complications such as strokes, heart attacks, and kidney problems. The other options do not pertain to the FDA-label indications for Enalapril. Asthma is typically managed with bronchodilators or corticosteroids, cholesterol management generally involves statins or other lipid-lowering agents, and diabetes management often requires insulin or oral hypoglycemic medications. Therefore, the specific targeting of hypertensive conditions makes option A the correct choice.

Enalapril Maleate is primarily indicated for the treatment of hypertension, which is high blood pressure. As an ACE (Angiotensin-Converting Enzyme) inhibitor, Enalapril works by relaxing blood vessels, allowing blood to flow more easily, thus lowering blood pressure. This indication is important because managing hypertension is crucial to prevent complications such as strokes, heart attacks, and kidney problems.

The other options do not pertain to the FDA-label indications for Enalapril. Asthma is typically managed with bronchodilators or corticosteroids, cholesterol management generally involves statins or other lipid-lowering agents, and diabetes management often requires insulin or oral hypoglycemic medications. Therefore, the specific targeting of hypertensive conditions makes option A the correct choice.